Intuitive Surgical, Inc. Dossier
|
SectorHealth Care IndustryHealth Care Equipment Beta (adjusted)1.31 Intrinsic Value $378.70median of 6 methods · middle span $368-$581based on filings through 30 Jun 2026 Market Price $426.70Price as of 16 Oct 2026 Near fair valueIntrinsic value is 11% below the market price −50% · IV below pricenear fair value ±15%IV above price · +50% Data confidence Sign in to view data confidence Market Cap $150.7B Enterprise Value $148B Shares Outstanding 356.8M diluted Moat Rating Wide Next Earnings Date20 Oct 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Intuitive's operating indicators remain strong: second-quarter 2026 da Vinci procedures increased 15%, Ion procedures increased 36%, the da Vinci installed base reached 11,710 systems, and 246 da Vinci 5 systems were placed. However, da Vinci growth moderated from 16% in the first quarter to 15% in the second quarter, and management expects full-year growth near the midpoint of its 13.5%-15.5% range. This section is the 12-month view: analyst targets and the scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$324.00 Mean target$478.01 High · most bullish analyst$685.00 Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $324.00 Da Vinci procedure growth falls below the 13.5% guidance floor, while Ion growth and da Vinci 5 placements decline from their second-quarter baselines. Hospital capital constraints, tariffs, supply disruption, regulatory delays, or competition—particularly in China—could contribute to this outcome. Base CaseCentral scenario $478.01 Matches the consensus meanDa Vinci procedure growth finishes near the midpoint of management's 13.5%-15.5% range, Ion continues growing faster than da Vinci, and da Vinci 5 adoption proceeds without a sustained placement decline. Bull CaseUpside scenario $685.00 Procedure growth reaches the upper end of management's 2026 range, Ion sustains growth near or above its second-quarter level, and da Vinci 5 placements remain at or above the second-quarter baseline, supporting continued expansion of the installed ecosystem. Scenarios are anchored to street consensus at the research date, with our rationale. Key Investment Merits
Key Investment Risks
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |